The Indian Council of Scientific and Industrial Research (CSIR) and Tata MD have collaborated to enhance access to Covid-19 testing in tier II and III towns as well as rural areas across India. The move aims to manage any future Covid-19 surge and testing requirements. As per the agreement, CSIR’s network of labs will be used to increase capacity to remote areas, while the RT-PCR CRISPR test will be conducted using the Tata MD CHECK SARS-CoV-2 test kits.
Co-Diagnostics has announced that its Logix Smart SARS-CoV-2 DS (direct saliva) test has sought regulatory authorisation to be sold as an in vitro diagnostic (IVD) for Covid-19 diagnosis in countries that accept the CE mark. The company also announced that the test is being sold from its Utah-based certified facility. The test eliminates RNA extraction of the samples, which the company believes increases the throughput and lowers Covid-19 testing costs, as well as the cost of other pathogen tests.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Roche has announced that its cobas SARS-CoV-2 Nucleic acid test was granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA). This is the first test Covid-19 RT-PCR test that can detect SARS-CoV-2 infection among symptomatic and asymptomatic individuals in just 20 minutes. It runs on the cobas Liat System, and will also be available in countries that accept the CE mark.
